Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium

Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infection (ARI) in older adults. This study used a static, cohort-based decision-tree model to estimate the public health and economic impact of vaccination against RSV in Belgians aged ≥60 years compared with no vaccination for different vaccine duration of protection profiles from a healthcare payer perspective. Three vaccine protection durations were compared (1, 3, and 5 years), and several sensitivity and scenario analyses were performed. Results showed that an RSV vaccine with a 3-year duration of protection would... Mehr ...

Verfasser: Maarten J. Postma
Chih-Yuan Cheng
Nasuh C. Buyukkaramikli
Luis Hernandez Pastor
Ine Vandersmissen
Thierry Van Effelterre
Peter Openshaw
Steven Simoens
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: Vaccines, Vol 11, Iss 5, p 990 (2023)
Verlag/Hrsg.: MDPI AG
Schlagwörter: respiratory syncytial virus / vaccine / older adults / health economic evaluation / Medicine / R
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26613311
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/vaccines11050990